Genomic Financial Statements From 2010 to 2024
Genomic Health financial statements provide useful quarterly and yearly information to potential Genomic Health investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Genomic Health financial statements helps investors assess Genomic Health's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Genomic Health's valuation are summarized below:Genomic Health does not presently have any fundamental trends for analysis.
This module can also supplement various Genomic Health Technical models . Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
Check Genomic Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genomic main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Genomic financial statements analysis is a perfect complement when working with Genomic Health Valuation or Volatility modules.
Genomic |
Genomic Health Company Profit Margin Analysis
Genomic Health's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Genomic Health Profit Margin | 0.08 % |
Most of Genomic Health's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genomic Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Genomic Health has a Profit Margin of 0.0808%. This is 100.72% lower than that of the Healthcare sector and significantly higher than that of the Medical Laboratories & Research industry. The profit margin for all United States stocks is 106.36% lower than that of the firm.
Genomic Health Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Genomic Health's current stock value. Our valuation model uses many indicators to compare Genomic Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genomic Health competition to find correlations between indicators driving Genomic Health's intrinsic value. More Info.Genomic Health is one of the top stocks in return on equity category among related companies. It is one of the top stocks in return on asset category among related companies reporting about 0.79 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Genomic Health is roughly 1.27 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Genomic Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Genomic Health's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Genomic Health's earnings, one of the primary drivers of an investment's value.Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Genomic Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Genomic Health's short interest history, or implied volatility extrapolated from Genomic Health options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Genomic Health information on this page should be used as a complementary analysis to other Genomic Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Genomic Stock
If you are still planning to invest in Genomic Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genomic Health's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |